| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/26/2005 | EP1500665A1 METHOD FOR CONSTRUCTING scDb LIBRARIES |
| 01/26/2005 | EP1500661A1 Separation of protein monomers from aggregates by use of ion-exchange chromatography |
| 01/26/2005 | EP1500431A2 Immobilised affinity medium and its use in separation |
| 01/26/2005 | EP1500400A1 Drug containing antibody composition |
| 01/26/2005 | EP1500399A1 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases |
| 01/26/2005 | EP1500329A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 01/26/2005 | EP1499896A1 Method for diagnosing neoplasms |
| 01/26/2005 | EP1499887A2 Universal libraries for immunoglobulins |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499726A1 Chimeric camp factors for vaccination against streptococcus infection |
| 01/26/2005 | EP1499725A1 Psp94 binding protein and psp94 diagnostic assays |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499642A1 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 01/26/2005 | EP1499641A1 Bispecific molecules for use in therapy and diagnosis of immune related and other diseases |
| 01/26/2005 | EP1499632A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/26/2005 | EP1499630A2 Streptavidin expressed gene fusions and methods of use thereof |
| 01/26/2005 | EP1499354A2 Methods of using cytokine antagonists to treat hiv infection and aids |
| 01/26/2005 | EP1499353A2 Antibodies that specifically bind to tl5 |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499351A2 Antibodies that specifically bind to tr2 |
| 01/26/2005 | EP1499350A2 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 01/26/2005 | EP1499346A2 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 01/26/2005 | EP1499343A1 A method of modulating cellular activity |
| 01/26/2005 | EP1499327A2 Beta -amyloid peptide-binding proteins and polynucleotides encoding the same |
| 01/26/2005 | EP1499292A1 In vivo imaging of apoptosis |
| 01/26/2005 | EP1438331A4 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 01/26/2005 | EP1127133B1 Polypeptide mediating cell permeability |
| 01/26/2005 | EP1092021B1 Npy-y7 receptor gene |
| 01/26/2005 | EP1001991A4 CRYSTAL STRUCTURES OF ANTI-FACTOR IX Fab FRAGMENTS AND METHODS OF USE FOR PEPTIDOMIMETIC DESIGN |
| 01/26/2005 | EP0998555A4 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen) |
| 01/26/2005 | EP0996636B1 The ha-1 antigen |
| 01/26/2005 | EP0934412B1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF |
| 01/26/2005 | EP0886651B1 Persephin and related growth factors |
| 01/26/2005 | EP0793717B1 Oral immunization with transgenic plants |
| 01/26/2005 | EP0652953B1 Morphogenic protein soluble complex and composition thereof |
| 01/26/2005 | EP0579758B1 Parathyroid hormone receptor and dna encoding same |
| 01/26/2005 | CN1571836A Human antibodies specific for interleukin 15 (IL-15) |
| 01/26/2005 | CN1571797A Anti-hla-dr antibody |
| 01/26/2005 | CN1571675A Treatment and diagnosis of insulin-resistant states |
| 01/26/2005 | CN1570109A Production method of trangenic plant for expressing hepatitis B virus envelop protein and its products |
| 01/26/2005 | CN1570106A Transcription related zinc belt protein , monoclonal antibody, preparation method and its uses |
| 01/26/2005 | CN1570100A Nerval incretion specific protein analog, its coding sequence, making method and uses |
| 01/26/2005 | CN1569900A Heavy chain variable region single domain antibody reinforced fusion protein VH-LDP-AE |
| 01/26/2005 | CN1569898A Recombinant human antibody against HBsAg and its preparation method |
| 01/26/2005 | CN1569897A Preparation method and use for polyclonal antibody against wheat glutenin subunit |
| 01/26/2005 | CN1569896A Preparation of composite specific yelk antibody igy against cutaneous infection and its use in treatment of cutaneous infection |
| 01/26/2005 | CN1569895A Yelk antibody specific for preventing pigling diarrhea and its preparing method and application |
| 01/26/2005 | CN1569879A Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use |
| 01/26/2005 | CN1569840A Production method and use for imidacloprid artificial hapten, artificial antigen and specific antibody |
| 01/26/2005 | CN1569835A Production method and use for dichloro quinolinic acid artificial hapten, artificial antigen and specific antibody |
| 01/26/2005 | CN1569231A Specific antibody IgY immune preparation and its application in the prevention and treatment of mycobacterium tuberculosis infection |
| 01/26/2005 | CN1569229A IgY product for resisting mouth and upper respiratory tract infection and its application |
| 01/26/2005 | CN1186445C Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application |
| 01/25/2005 | US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders |
| 01/25/2005 | US6846912 Monoclonal antibody specific for leukocyte antigen related (LAR) phosphatase for diagnosis and treatment of thyroid cancer insulin resistance and arteriosclerosis |
| 01/25/2005 | US6846911 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit |
| 01/25/2005 | US6846908 DCR-5 bone affecting ligand |
| 01/25/2005 | US6846907 Osteoporosis treatment |
| 01/25/2005 | US6846883 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 01/25/2005 | US6846803 Hybrid polynucleotide |
| 01/25/2005 | US6846672 Mitogenic oxygenase regulators |
| 01/25/2005 | US6846662 Vertebrate telomerase genes and proteins and uses thereof |
| 01/25/2005 | US6846654 Catalytic antibodies as chemical sensors |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846644 Detection of modulators or kinase activity; obtain sample containing kinase, incubate with modulators, monitor adjustment in enzyme activity, adjustment in activity indicates modulator |
| 01/25/2005 | US6846637 Preparing chimeric antibodies for diagnosis and treatment of cell proliferative disorders |
| 01/25/2005 | US6846634 Method to screen phage display libraries with different ligands |
| 01/25/2005 | US6846486 Vaccine; therapy, prevention asthma; mixture of antihistamine antibody and interferons; antiallergens |
| 01/25/2005 | US6846410 Comprises ethylenediamine-N,N-tetra(methylenephosphonic) acid; for ion exchange/chromatography; improved biocompability |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/20/2005 | WO2005005984A1 Method of diagnosing disease relating to endometriosis |
| 01/20/2005 | WO2005005638A2 High affinity fusion proteins (rc-scfv-fc or scfv-scfv-fc) binding cytokines, particularly il-6 & il-18 |
| 01/20/2005 | WO2005005636A1 IgM PRODUCTION BY TRANSFORMED CELL AND METHOD OF QUANTIFYING THE SAME |
| 01/20/2005 | WO2005005635A2 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/20/2005 | WO2005005631A1 Hla-a24 binding cancer antigen peptide derived from ribin |
| 01/20/2005 | WO2005005627A2 Applications of a new class of enzymes: sulfiredoxines. |
| 01/20/2005 | WO2005005623A1 Method for lysys for tumor cells |
| 01/20/2005 | WO2005005615A2 Anti-mullerian inhibiting substance type ii receptor (misiir) immunoconjugates to detect and treat cancer |
| 01/20/2005 | WO2005005604A2 Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
| 01/20/2005 | WO2005005483A1 Emitter-binding peptides causing a change in the spectral emission properties of the emitter |
| 01/20/2005 | WO2005005482A1 Emitter-binding peptides, which cause a modification of the spectral emission characteristics of the emitter |
| 01/20/2005 | WO2005005481A2 Combination therapy for gastroenteric diseases caused by microorganisms |
| 01/20/2005 | WO2005005479A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 01/20/2005 | WO2005005474A1 Atopic dermatitis inducer |
| 01/20/2005 | WO2005005472A1 Use of a novel eimeria gene and corresponding protein |
| 01/20/2005 | WO2005005468A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 01/20/2005 | WO2005005462A2 Blys antagonists and uses thereof |
| 01/20/2005 | WO2005005455A2 Specific human antibodies |
| 01/20/2005 | WO2005004912A1 Method for treating synovial sarcoma |
| 01/20/2005 | WO2005004904A1 Method for treating diseases associated with modifications of qualitative and/ quantitative composition of blood extracellular dna (variants) |
| 01/20/2005 | WO2005004809A2 Multivalent carriers of bi-specific antibodies |
| 01/20/2005 | WO2005004800A2 Trypanosome derived apoptotic factors (taf) |
| 01/20/2005 | WO2005004793A2 Compositions and methods for treating coagulation related disorders |
| 01/20/2005 | WO2004106385A3 Monoclonal antibodies specific for buprenorphine and metabolites thereof |
| 01/20/2005 | WO2004092208A3 Sars-related proteins |
| 01/20/2005 | WO2004089386A8 Antiobestic agent using hen’s egg antibody against digestive enzymes |
| 01/20/2005 | WO2004087758A3 Il 13 receptor alpha 2 antibody and methods of use |
| 01/20/2005 | WO2004087207A3 Method for inducing apoptosis and aneuploidy regression in cancer cells |
| 01/20/2005 | WO2004083382A3 Compositions and methods for treating hyperimmune response in the eye |
| 01/20/2005 | WO2004048925A3 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |